Cargando…

MRI grading for the prediction of prostate cancer aggressiveness

OBJECTIVES: T o evaluate the value of multiparametric MRI (mpMRI) for the prediction of prostate cancer (PCA) aggressiveness. METHODS: In this single center cohort study, consecutive patients with histologically confirmed PCA were retrospectively enrolled. Four different ISUP grade groups (1, 2, 3,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boschheidgen, M., Schimmöller, L., Arsov, C., Ziayee, F., Morawitz, J., Valentin, B., Radke, K. L., Giessing, M., Esposito, I., Albers, P., Antoch, G., Ullrich, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Urogenital
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921105/ https://www.ncbi.nlm.nih.gov/pubmed/34748064 http://dx.doi.org/10.1007/s00330-021-08332-8

Ejemplares similares

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
por: Ullrich, T., et al.
Publicado: (2020)

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
por: Boschheidgen, M., et al.
Publicado: (2022)

Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study
por: Michallek, Florian, et al.
Publicado: (2021)

The primacy of multiparametric MRI in men with suspected prostate cancer
por: Richenberg, Jonathan, et al.
Publicado: (2019)

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
por: Caglic, Iztok, et al.
Publicado: (2020)

mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging
por: Gatti, Marco, et al.
Publicado: (2022)

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
por: Wallström, Jonas, et al.
Publicado: (2021)

The longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRI
por: Barrett, Tristan, et al.
Publicado: (2017)

Accuracy of fractal analysis and PI-RADS assessment of prostate magnetic resonance imaging for prediction of cancer grade groups: a clinical validation study
por: Michallek, Florian, et al.
Publicado: (2021)

Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2021)

Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
por: Schouten, Martijn G., et al.
Publicado: (2011)

3D T2-weighted imaging to shorten multiparametric prostate MRI protocols
por: Polanec, Stephan H., et al.
Publicado: (2017)

Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization
por: Boschheidgen, Matthias, et al.
Publicado: (2023)

Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
por: Giganti, Francesco, et al.
Publicado: (2022)

Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment
por: Schelb, Patrick, et al.
Publicado: (2020)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
por: Bernatz, Simon, et al.
Publicado: (2020)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019)

Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection
por: Ziayee, Farid, et al.
Publicado: (2021)

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
por: Huebner, Nicolai Alexander, et al.
Publicado: (2020)

MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences
por: Bura, Vlad, et al.
Publicado: (2021)

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
por: Quentin, M., et al.
Publicado: (2022)

Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023)

ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training
por: de Rooij, Maarten, et al.
Publicado: (2020)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

MRI of the kidney—state of the art
por: Nikken, J. J., et al.
Publicado: (2007)

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
por: Valentin, B., et al.
Publicado: (2021)

Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
por: Beheshti, Mohsen, et al.
Publicado: (2022)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
por: Klingebiel, M, et al.
Publicado: (2022)

ESUR prostate MR guidelines 2012
por: Barentsz, Jelle O., et al.
Publicado: (2012)

Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis
por: Beer, Lucian, et al.
Publicado: (2020)

Role of radiomic analysis of [(18)F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging
por: Marturano, Francesca, et al.
Publicado: (2023)

Structured reporting of pelvic MRI leads to better treatment planning of uterine leiomyomas
por: Sala, Evis, et al.
Publicado: (2018)

Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer
por: Wildeboer, Rogier R., et al.
Publicado: (2016)

Non-contrast MRI can accurately characterize adnexal masses: a retrospective study
por: Sahin, Hilal, et al.
Publicado: (2021)

Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy
por: Hansen, Nienke L., et al.
Publicado: (2016)

MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines
por: Maciel, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2bnikkhuir5bsv30mpe9j8c1m5